GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » Asset Impairment Charge

Ananda Developments (AQSE:ANA) Asset Impairment Charge : £0.00 Mil (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments Asset Impairment Charge?

Ananda Developments's Asset Impairment Charge for the six months ended in Jul. 2023 was £0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2023 was £0.00 Mil.

Ananda Developments Asset Impairment Charge Historical Data

The historical data trend for Ananda Developments's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Asset Impairment Charge Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Asset Impairment Charge
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Developments Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Ananda Developments Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Developments (AQSE:ANA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » Asset Impairment Charge
Comparable Companies
LSE:HELD LSE:N4P LSE:PXS LSE:CHLL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
1FX:Germany
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Website
http://www.anandadevelopments.com
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines